BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28027515)

  • 1. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
    Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
    Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
    Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?
    Sun Myint A; Smith FM; Gollins SW; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman MJ; Fekete Z; Perkins K; Pritchard DM
    Br J Radiol; 2017 Dec; 90(1080):20170175. PubMed ID: 28937269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - Preliminary results of the CONTEM1 study.
    Dhadda A; Sun Myint A; Thamphya B; Hunter I; Hershman M; Gerard JP
    Radiother Oncol; 2021 Sep; 162():195-201. PubMed ID: 34329654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV.
    Gerard JP; Myint AS; Barbet N; Dejean C; Thamphya B; Gal J; Montagne L; Vuong T
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
    Sun Myint A; Smith FM; Gollins S; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman M; Pritchard DM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):565-573. PubMed ID: 29229327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
    Ortholan C; Romestaing P; Chapet O; Gerard JP
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e165-71. PubMed ID: 22579379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer.
    Gerard JP; Montagne L; Thamphya B; Doyen J; Schiappa R; Benezery K; Gourgou S; Dejean C; Hannoun-Levi JM
    Clin Transl Radiat Oncol; 2022 Mar; 33():70-76. PubMed ID: 35118202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low energy contact X-ray brachytherapy for treatment of rectal cancer: a health technology appraisal by Health Technology Wales.
    Bennett H; Rao C; Batten L; Hasler E; Jarrom D; Prettyjohns M; Barrington C; Sun Myint A
    Colorectal Dis; 2024 May; 26(5):1053-1058. PubMed ID: 38467574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
    Sun Myint A; Rao C; Barbet N; Thamphya B; Pace-Loscos T; Schiappa R; Magné N; Martel-Lafay I; Mineur L; Deberne M; Zilli T; Dhadda A; Gerard JP
    Colorectal Dis; 2023 Nov; 25(11):2160-2169. PubMed ID: 37837240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence.
    Benezery K; Montagne L; Evesque L; Schiappa R; Hannoun-Levi JM; Francois E; Thamphya B; Gerard JP
    Clin Transl Radiat Oncol; 2020 Sep; 24():92-98. PubMed ID: 32695890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact X-ray therapy for rectal cancer: experience in Centre Antoine-Lacassagne, Nice, 2002-2006.
    Gérard JP; Ortholan C; Benezery K; Ginot A; Hannoun-Levi JM; Chamorey E; Benchimol D; François E
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):665-70. PubMed ID: 18455327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud - nice experience using contact x-ray brachytherapy and external beam radiotherapy for 120 patients.
    Gerard JP; Frin AC; Doyen J; Zhou FX; Gal J; Romestaing P; Barbet N; Coquard R; Chapet O; François E; Marcié S; Benezery K
    Acta Oncol; 2015 Apr; 54(4):545-51. PubMed ID: 25389568
    [No Abstract]   [Full Text] [Related]  

  • 15. Contact X-ray Brachytherapy as an Adjunct to a Watch and Wait Approach is an Affordable Alternative to Standard Surgical Management of Rectal Cancer for Patients with a Partial Clinical Response to Chemoradiotherapy.
    Rao C; Stewart A; Martin AP; Collins B; Pritchard DM; Athanasiou T; Sun Myint A
    Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):625-633. PubMed ID: 30196845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cohort study of local excision followed by adjuvant therapy incorporating a contact X-ray brachytherapy boost instead of radical resection in 180 patients with rectal cancer.
    Smith FM; Pritchard DM; Wong H; Whitmarsh K; Hershman MJ; Sun Myint A
    Colorectal Dis; 2019 Jun; 21(6):663-670. PubMed ID: 30742736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy and local excision for sphincter preservation in T1 and T2 rectal cancer.
    Grimard L; Stern H; Spaans JN
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):803-9. PubMed ID: 19250765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
    Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
    Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review.
    Buckley H; Wilson C; Ajithkumar T
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):111-127. PubMed ID: 28816137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.